Overview
Hannah focuses her practice on litigation, focusing on commercial and contractual disputes. Dedicated, strategic, and detail-oriented, she protects her clients’ interests by providing practical guidance that minimizes disruption and aligns with their business goals.
During law school, Hannah externed with the Franklin County Court of Common Pleas and at the Ohio Supreme Court in Justice Jennifer Brunner’s chambers. There, she wrote jurisdictional memorandums on certiorari petitions, conducted legal research and prepared a bench memorandum, gaining insight into various areas of litigation. As Executive Editor of the Ohio State Law Journal, she managed a team of over 90 law students, developing strong organizational and leadership skills.
What I Do
Experience
Represented a natural gas pipeline company in a dispute over property damage caused by a contractor exceeding mowing limits on a pipeline right-of-way. Benesch secured dismissal of claims against the parent company and obtained voluntary dismissal of our client after clarifying easement terms and contractor responsibility.
No results found
Credentials
Education
- Executive Editor, Ohio State Law Journal
- CALI Award, Contracts II
- ABA National Appellate Advocacy Competition Travel Team
- Awarded Best Overall and Best Brief, 1L Moot Court Competition
- Moot Court Governing Board Justice of Lawyering Skills
- Minor in Professional Writing
Bar & Court Admissions
Related News & Insights
Tracking Pixels on Automated Website Held Not to Violate Washington Privacy Act
Key Takeaways Earlier this week, the Washington Supreme Court unanimously affirmed dismissal of a putative class action alleging that Seattle …
Burned by the Label? What Sunscreen SPF Class Actions Mean for Consumer Product Companies
Key Takeaways: Every sunscreen bottle makes one promise in big type: the SPF number. A growing wave of putative class …
Science-Backed But Not FDA-Approved: New Lawsuit Challenges FDA’s Rejection of 114 Health-Related Advertising Claims
A new lawsuit challenges the FDA’s rejection of 114 health-related advertising claims for supplements, arguing that the agency’s narrow interpretation of what counts as an “authoritative statement” unfairly blocks science-backed—but not FDA-approved—claims from appearing on product labels.